Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Air pollution and disease progression among patients with primary glomerular disease: an expanded study with extended follow-up.

Environmental health : a global access science source·2026

Same author

Length of Follow-Up Time Needed for Stable eGFR Slope Estimation in Glomerular Disease.

Kidney360·2026

Same author

Text Messaging for Longitudinal Data Collection From Adults With Glomerular Disease: Lessons From the Cure Glomerulonephropathy Network.

Kidney medicine·2026

Same author

Defining Disease Modification in IgA Nephropathy: Toward a Paradigm Shift in Management.

Kidney international reports·2025

Same author

The landscape of allele-specific expression in human kidneys.

bioRxiv : the preprint server for biology·2025

Same author

Clinical Relevance of Computationally Derived Attributes of Arteries and Arterioles in focal segmental glomerulosclerosis and minimal change disease.

medRxiv : the preprint server for health sciences·2025

Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026

Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026

Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026

Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026

Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026

Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 22, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Machine learning, the kidney, and genotype-phenotype analysis.

Rachel S G Sealfon¹, Laura H Mariani², Matthias Kretzler²

¹Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, New York, USA.

Kidney International

|May 4, 2020

Summary

This summary is machine-generated.

Machine learning analyzes large kidney datasets, including omics and health records, to uncover disease insights. This approach is crucial for understanding the link between genes and observable traits in kidney disease research.

Keywords:

deep learning genotype machine learning

More Related Videos

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Experiment Videos

Last Updated: Dec 22, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Area of Science:

Biomedical research
Data science
Machine learning in medicine

Background:

Biomedical research is increasingly data-intensive.
Machine learning (ML) offers tools for analyzing large biological datasets.
Growing availability of kidney-specific omics, electronic health records, and imaging data.

Purpose of the Study:

To discuss the application of ML in kidney disease research.
To highlight ML's role in analyzing diverse human kidney datasets.
To focus on using ML for genotype-phenotype relationship studies in kidney disease.

Main Methods:

Utilizing machine learning algorithms.
Analyzing comprehensive kidney omics data (transcriptomics, proteomics, metabolomics, genome sequencing).
Integrating diverse data modalities: electronic health records, digital nephropathology, and radiology images.

Main Results:

Machine learning is essential for analyzing complex human kidney datasets.
ML facilitates knowledge extraction from large-scale biological data.
ML approaches are key to understanding genotype-phenotype correlations in kidney disease.

Conclusions:

Machine learning is a powerful toolkit for data-rich biomedical research.
ML is increasingly vital for analyzing human kidney data.
ML enables deeper understanding of kidney disease mechanisms, particularly genotype-phenotype links.